NWO Domain Applied and Engineering Sciences (AES) has granted project ULTRA-X-TREME 4 million euros for developing new 3D ultrasound techniques allowing patient-specific diagnosis of vascular problems and prevention of unnecessary operations. The project is led by Chris de Korte, professor of Medical Ultrasound Techniques at Radboudumc and professor of Medical Ultrasound Imaging at the University of Twente.Vascular problems may have life-threatening consequences. For instance, ischemic cerebrovascular accidents are often caused by carotid artery atherosclerosis, and fatal rupture of the abdominal aorta often results from vascular wall weakening. Doctors may use echography to assess the risk of vascular complications by measuring the diameter of the vessels in question. However, this method is shown to have only limited predictive value. As a result, unnecessary and risky treatments are given, whereas high-risk cases remain unidentified.
As part of the program Ultrafast Ultrasound Imaging for Extended Diagnosis and Treatment of Vascular Disease (ULTRA-X-TREME), an international research team is to develop new and more accurate three-dimensional vascular wall and perfusion ultrasound imaging techniques. The team has been granted four million euros by the funding instrument Perspectief of NWO Domain AES. In the next five years, under the supervision of Chris de Korte, professor of Medical Ultrasound Techniques at Radboud university medical center and professor of Medical Ultrasound Imaging at the University of Twente, the researchers will develop new ultrasound sensors, contrast agents and analysis techniques to more accurately assess the necessity of vascular treatment.
The ULTRA-X-TREME consortium is a collaboration of hospitals, international industrial partners and Dutch research groups with a focus on ultrasound techniques and vascular biomechanics. In alphabetical order, the participants in the program are: ANSYS, Bracco Suisse S.A., Catharina Hospital, Erasmus MC, Harteraad, Mindray, Dutch Society for Vascular Surgery (NVvV), Philips Electronics Netherlands, Pie Medical Imaging, Radboud university medical center, Rijnstate Hospital, Delft University of Technology, Eindhoven University of Technology, TomTec Imaging Systems, University of Twente, Vermon S.A. and Verasonics.
Chris de Korte is member of theme Vascular damage.
Related news items
New research through grants for Radboudumc researchers14 January 2021
Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.read more
Should we prepare for a corona-related depression wave? Indira Tendolkar and Eric Ruhé talk about their research projects13 January 2021
Since the outbreak of the SARS-CoV-2, many of us have been staying at home in order to limit our social interactions, to keep ourselves and others safe from the virus. Yet, there’s also concern about what social distancing and anxiety generated by media reports are doing to people's mental health.read more
RIMLS online award ceremony proudly presenting the winners13 January 2021
In this special webinar of the RIMLS New Year Celebration, scientific director René Bindels reviewed 2020 and looked forward to 2021. But more importantly a number of researchers received prizes in the traditional RIMLS awards ceremony.read more
Cooling vests alleviate perceptual heat strain perceived by COVID-19 nurses11 January 2021
Wearing cooling vests during a COVID-19 shift ensures that nurses experience less heat during their work. The cooling vests offer such effective cooling that they are now part of the standard work clothing for nurses in the COVID nursing departments at Radboudumc.read more
Koen van den Dries received ENW-XS grant from the NWO7 January 2021
Koen van den Dries has received an ENW-XS grant from the NWO for his project titled: Small differences, large impact: how actin variants differentially control cancer cell migration.read more